MX2024005600A - Metodos y composiciones para tratar afecciones asociadas con hipoventilacion central. - Google Patents
Metodos y composiciones para tratar afecciones asociadas con hipoventilacion central.Info
- Publication number
- MX2024005600A MX2024005600A MX2024005600A MX2024005600A MX2024005600A MX 2024005600 A MX2024005600 A MX 2024005600A MX 2024005600 A MX2024005600 A MX 2024005600A MX 2024005600 A MX2024005600 A MX 2024005600A MX 2024005600 A MX2024005600 A MX 2024005600A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- conditions associated
- treating conditions
- compositions
- central hypoventilation
- Prior art date
Links
- 206010021133 Hypoventilation Diseases 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 229940122072 Carbonic anhydrase inhibitor Drugs 0.000 abstract 2
- 239000003489 carbonate dehydratase inhibitor Substances 0.000 abstract 2
- 239000002767 noradrenalin uptake inhibitor Substances 0.000 abstract 2
- 229940127221 norepinephrine reuptake inhibitor Drugs 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163278324P | 2021-11-11 | 2021-11-11 | |
| US202263305305P | 2022-02-01 | 2022-02-01 | |
| PCT/US2022/049483 WO2023086433A1 (en) | 2021-11-11 | 2022-11-10 | Methods and compositions for treating conditions associated with central hypoventilation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024005600A true MX2024005600A (es) | 2024-05-21 |
Family
ID=84627454
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024005600A MX2024005600A (es) | 2021-11-11 | 2022-11-10 | Metodos y composiciones para tratar afecciones asociadas con hipoventilacion central. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250000823A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4429649A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024541315A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240108453A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022387440A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3237151A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL312688A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024005600A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023086433A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025207125A1 (en) * | 2024-03-26 | 2025-10-02 | The Regents Of The University Of California | Combination pharmacological interventions for obstructive sleep apnea |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| EP3685858A1 (en) * | 2019-01-24 | 2020-07-29 | Assistance Publique-Hopitaux De Paris | A noradrenergic system stimulator in the treatment of central hypoventilation syndromes |
| US20220362221A1 (en) * | 2019-11-04 | 2022-11-17 | Apnimed, Inc. (Delaware) | Combination pharmacological interventions for multiple mechanisms of obstructive sleep apnea |
-
2022
- 2022-11-10 MX MX2024005600A patent/MX2024005600A/es unknown
- 2022-11-10 US US18/709,055 patent/US20250000823A1/en active Pending
- 2022-11-10 KR KR1020247019140A patent/KR20240108453A/ko active Pending
- 2022-11-10 EP EP22830640.3A patent/EP4429649A1/en active Pending
- 2022-11-10 IL IL312688A patent/IL312688A/en unknown
- 2022-11-10 AU AU2022387440A patent/AU2022387440A1/en active Pending
- 2022-11-10 JP JP2024527312A patent/JP2024541315A/ja active Pending
- 2022-11-10 WO PCT/US2022/049483 patent/WO2023086433A1/en not_active Ceased
- 2022-11-10 CA CA3237151A patent/CA3237151A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20250000823A1 (en) | 2025-01-02 |
| EP4429649A1 (en) | 2024-09-18 |
| WO2023086433A1 (en) | 2023-05-19 |
| KR20240108453A (ko) | 2024-07-09 |
| JP2024541315A (ja) | 2024-11-08 |
| CA3237151A1 (en) | 2023-05-19 |
| AU2022387440A1 (en) | 2024-05-23 |
| IL312688A (en) | 2024-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2023000622S1 (es) | Banda para dispositivo | |
| CL2021000384S1 (es) | Banda tipo pulsera para un dispositivo. | |
| CL2023000619S1 (es) | Banda para dispositivo | |
| CL2023000608S1 (es) | Banda para dispositivo | |
| CL2023000613S1 (es) | Banda para dispositivo | |
| CO2021008776A2 (es) | Inhibidores de il-17a | |
| DOP2025000200A (es) | Compuestos y métodos para modular ras-pi3k | |
| CL2023000223A1 (es) | Nuevos inhibidores selectivos de hdac6 basados en oxadiazol | |
| BR112021020285A2 (pt) | Métodos e composições para degradação de proteína alvejada | |
| CL2021000385S1 (es) | Banda tipo pulsera para un dispositivo. | |
| BR112022021381A2 (pt) | Compostos para o tratamento de sars | |
| ECSP099525A (es) | Inhibidores de mek | |
| CL2021001461A1 (es) | Moduladores de trex1 | |
| BR112013018779A2 (pt) | composto, composição farmacêutica, e, método para tratar uma condição ou um distúrbio | |
| CL2024000731S1 (es) | Banda para dispositivo. | |
| CL2023000611S1 (es) | Banda para dispositivo | |
| MX2021010869A (es) | Bloqueadores de canales iónicos sustituidos por éster y métodos para su uso. | |
| CL2023000615S1 (es) | Banda para dispositivo | |
| MX2021000469A (es) | Inhibidores biciclicos de las histona desacetilasas. | |
| BR112022023187A2 (pt) | Compostos para o tratamento da sars | |
| CO2025001287A2 (es) | Inhibidores de la proteasa principal de sars-cov2 | |
| EP4486741A4 (en) | Diacylglycerol Kinase (DGK) Alpha Inhibitors and Their Uses | |
| JOP20220290A1 (ar) | مثبطات إنزيم الجلوكوسيل سيراميداز غير المتعلقة بالجسيم الحال واستخدامتها | |
| EA202190077A1 (ru) | Ингибиторы гистондеацетилазы | |
| GEP20257794B (en) | Magl inhibitor |